维普中文期刊产品整合服务
73篇 您的检索式:作者名="Hobisch"
    题名 作者 年代 出处 被引量
1Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor,keratinocyte growth factor and epidermal growth factor显示文摘 HOBISCH A CRONAUER M 1994Cancer Res1994,54,21:1
2Regulation of prostatic growth and function by peptide growth factors显示文摘Culig Z Hobisch A Cronaner MV 1996Prostate1996,28,:1
3Elevated levels of serum secretoneurin in patients with therapy resistant carcinoma of the prostate显示文摘Ischia R Hobisch A Bauer R 2000J Urol2000,163,4:1
4Androgen receptor-an update of mechanisms of action in prostate cancer显示文摘Culig Z Hobisch A Bartsch G 2000Urol Res2000,28,4:1
5Transforming growth faetor-betal and beta2 in serum and urine from patients with bladder carcinoma 显示文摘EDER I E STENZL A HOBISCH A 1996J Urol1996,156,3:1
6Blunted erythropoietic response to anemia inmultiply traumatized patients显示文摘Hobisch HP Wiedermann F Mayr A 2001Crit Care Med2001,29,4:1
7Prostate cancer cells (LNCaP) generated after long-term inter leukin-6 (IL-6) treatment express IL-6 and aquire an IL-6 partially resistant phenotype显示文摘Hobisch A Ramoner R Fuchs D 2001Clin Cancer Res2001,7,:1
8Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone显示文摘Culig Z Hobisch A Cronauer M V 1993Mol Endocrinol1993,7,12:1
9Coaesequences of acute normovolaemic haemodilution on haemostasis during major orthopaeedic surgery 显示文摘Hobisch HP Wirleitner B Mair J 1999Br J Anaesth1999,82,4:1
10Life aftercystectomy and orthotopic neobladder versus ileal conduit urinary diversion显示文摘HOBISCH A TOSUN K KINZL J 2001Semin Urol Oncol2001,19,1:1
11Activation of the androgen receptor by polypeptide growth factors and cellular regulators显示文摘Culig Z Hobisch A Cronauer M V 1995World J Urol1995,13,4:1
12Mechanisms of endocrine therapy-responsive and unresponsive prostate tumours 显示文摘Culig Z Steiner H Bartsch G Hobisch A 2005Endocr Relat Cancer2005,12,:1
13Ureteroileal anastomosis in orthotopic urinary diversion:how much or how little is necessary?显示文摘Stenzl A Hobisch A Strasser H 2001Tech Urol2001,7,3:1
14Immunohistoehemical localization of interleukin-6 and its receptor in benign, premalig- nant and malignant prostate tissue显示文摘Hobisch A Rogatsch H Hittmair A 2000J Pathol2000,191,3:1
15Tumor-infiltrating T lymphocytes from renal-cell carcinoma express B7-1(CD80):T-cell expansion by T-T cell costimaulation 显示文摘Thurnher M Radrnayr C Hobisch A 1995Int J Cancer1995,62,5:1
16Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue 显示文摘HOBISCH A ROGATSCH H HITTMAIR A 2000J Pathol2000,191,3:1
17Intedeukin lbeta mediates the modulatory effects of monocytes on LNCaP human prostate cancer cells 显示文摘Culig Z Hobisch A Herold M 1998Br J Cancer1998,78,8:1
18Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor 显示文摘HOBISCH A EDER IE PUTZ T 1998Cancer Res1998,58,20:1
19Switch from antagonist to agonist of the androgen receptor biealutamide is associated with prostate tumour progression in a new model system显示文摘Culig Z Hoffmann J Erdel M Eder I E Hobisch A Hittmair A 1999Br J Cancer1999,81,:1
20Expression of transforming growth factors beta-l, beta2 and beta3 in human bladder carcinomas 显示文摘Eder IE Stenzl A Hobisch A 1997Br J Cancer1997,75,:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费